What question did this study set out to answer?

The aim is to assess the effectiveness of monoclonal antibodies in treating B-cell non-Hodgkin's lymphoma.

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

View Full Paper

Ask AI

Bookmark

Authors

Review evaluates monoclonal antibody effects on B-cell non-Hodgkin's lymphoma, suggesting improved outcomes and treatment options.

The aim is to assess the effectiveness of monoclonal antibodies in treating B-cell non-Hodgkin's lymphoma.
Review existing literature on monoclonal antibody treatments for B-cell non-Hodgkin's lymphoma.
Analyze outcomes when combined with chemotherapy.
Evaluate options for patients with refractory disease.
Monoclonal antibodies show improved treatment outcomes for B-cell non-Hodgkin's lymphoma.
They reduce the toxic effects often associated with chemotherapy.
Offer new therapeutic options for patients no longer responding to standard treatments.

Cheson et al. (2008) studied this question.

View Full Paper

Ask AI

Bookmark